Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Baoliga Biotechnology is a specialized biotechnology enterprise focused on the research, production, and global distribution of sodium hyaluronate (hyaluronic acid). Based in Qufu, China, the company utilizes advanced microbial fermentation and purification technologies to manufacture high-purity hyaluronic acid for the pharmaceutical, cosmetic, and food industries. Their product portfolio includes specialized grades such as injection-grade for orthopedics, eye-drop grade for ophthalmology, and various cosmetic and food-grade variants. Baoliga is recognized for its adherence to international quality standards, holding certifications such as ISO9001, HACCP, and GMP, which support its role as a key supplier in the life sciences supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Baoliga.